---
title: "MDR rule 8: Implantable and long-term surgically invasive devices"
url: https://normiq.app/en/classification/mdr/rule-8
language: en
updated: 2026-11-15
---

# MDR rule 8: Implantable and long-term surgically invasive devices

MDR · Annex VIII, Section 5.4 · INVASIVE DEVICES

Updated on November 15, 2026

## Official text

All implantable devices and long-term surgically invasive devices are classified as class IIb unless they:

- are intended to be placed in the teeth, in which case they are classified as class IIa;
- are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system, in which case they are classified as class III;
- have a biological effect or are wholly or mainly absorbed, in which case they are classified as class III;
- are intended to undergo chemical change in the body in which case they are classified as class III, except if the devices are placed in the teeth;
- are intended to administer medicinal products, in which case they are classified as class III;
- are active implantable devices or their accessories, in which cases they are classified as class III;
- are breast implants or surgical meshes, in which cases they are classified as class III;
- are total or partial joint replacements, in which case they are classified as class III, with the exception of ancillary components such as screws, wedges, plates and instruments; or
- are spinal disc replacement implants or are implantable devices that come into contact with the spinal column, in which case they are classified as class III with the exception of components such as screws, wedges, plates and instruments.

MDR, Annex VIII, Section 5.4, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/8](https://normiq.app/en/mdr/annexe/viii/8)

## In plain words

Implantable devices and long-term surgically invasive devices are in class IIb, or class IIa if placed in the teeth. They are in class III in direct contact with the heart, the central circulatory system or the central nervous system, if they have a biological effect, are wholly or mainly absorbed, undergo chemical change in the body (except in the teeth) or administer medicinal products, and for active implantable devices and their accessories, breast implants, surgical meshes, total or partial joint replacements and spinal disc replacements or implants in contact with the spinal column, with the exception, for the last two, of components such as screws, wedges, plates and instruments.

Explanation written by Normiq; only the official text above is authoritative.

## Definitions the rule relies on

- MDR, Article 2, point 6

  ‘invasive device’ means any device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body;

- MDR, Annex VIII, Section 2.1

  ‘Body orifice’ means any natural opening in the body, as well as the external surface of the eyeball, or any permanent artificial opening, such as a stoma.

- MDR, Annex VIII, Section 2.2

  ‘Surgically invasive device’ means:

  - an invasive device which penetrates inside the body through the surface of the body, including through mucous membranes of body orifices with the aid or in the context of a surgical operation; and
  - a device which produces penetration other than through a body orifice.

- MDR, Article 2, point 5

  ‘implantable device’ means any device, including those that are partially or wholly absorbed, which is intended:

  - to be totally introduced into the human body, or
  - to replace an epithelial surface or the surface of the eye,
  - by clinical intervention and which is intended to remain in place after the procedure.
  - Any device intended to be partially introduced into the human body by clinical intervention and intended to remain in place after the procedure for at least 30 days shall also be deemed to be an implantable device;

- MDR, Annex VIII, Section 1.1

  ‘Transient’ means normally intended for continuous use for less than 60 minutes.

- MDR, Annex VIII, Section 1.2

  ‘Short term’ means normally intended for continuous use for between 60 minutes and 30 days.

- MDR, Annex VIII, Section 1.3

  ‘Long term’ means normally intended for continuous use for more than 30 days.

- MDR, Annex VIII, Section 3.6

  In calculating the duration referred to in Section 1, continuous use shall mean:

  - the entire duration of use of the same device without regard to temporary interruption of use during a procedure or temporary removal for purposes such as cleaning or disinfection of the device. Whether the interruption of use or the removal is temporary shall be established in relation to the duration of the use prior to and after the period when the use is interrupted or the device removed; and
  - the accumulated use of a device that is intended by the manufacturer to be replaced immediately with another of the same type.

- MDR, Annex VIII, Section 2.6

  ‘Central circulatory system’ means the following blood vessels: arteriae pulmonales, aorta ascendens, arcus aortae, aorta descendens to the bifurcatio aortae, arteriae coronariae, arteria carotis communis, arteria carotis externa, arteria carotis interna, arteriae cerebrales, truncus brachiocephalicus, venae cordis, venae pulmonales, vena cava superior and vena cava inferior.

- MDR, Annex VIII, Section 2.7

  ‘Central nervous system’ means the brain, meninges and spinal cord.

- MDR, Annex VIII, Section 3.2

  If the device in question is intended to be used in combination with another device, the classification rules shall apply separately to each of the devices. Accessories for a medical device shall be classified in their own right separately from the device with which they are used.

## Examples from the MDCG guidance

The guidance lists these examples under rule 8 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class IIa

- Bridges and crowns

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 39

### Class IIb

- Intra-ocular lenses

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 39

### Class III

- Prosthetic heart valves

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 39

- Breast implants

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 40

- Implantable cardiac pacemakers

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 40

- Accessories to active implantable devices (with or without contact to the heart), be it implantable or non-implantable active or not: torque wrench for implantable pulse generator / implantable cardioverter defibrillator

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 40

- Accessories to active implantable devices (with or without contact to the heart), be it implantable or non-implantable active or not: cables for programmer / pacing system analyser

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 40

- Accessories to active implantable devices (with or without contact to the heart), be it implantable or non-implantable active or not: magnet for Implantable Pulse Generator / Implantable Cardioverter Generator

  MDCG 2021-24 Rev.1, 4.2, Rule 8, p. 40

- Also non-implantable and non-active accessories to AIMDs should be classified as Class III under Rule 8.

  MDCG 2021-24 Rev.1, 4.2, Rule 8, Note 6, p. 41

## Classes and Normiq roadmaps

Rule 8 assigns: Class IIa, Class IIb, Class III. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class IIa

- [European Union 15 phases · 66 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iia)
- [Switzerland 16 phases · 74 steps · estimated duration 120 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iia)
- [European Union and Switzerland 17 phases · 82 steps · estimated duration 300 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iia)

### Class IIb

- [European Union 15 phases · 68 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iib)
- [Switzerland 16 phases · 77 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iib)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 420 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iib)

### Class III

- [European Union 15 phases · 68 steps · estimated duration 540 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iii)
- [Switzerland 16 phases · 77 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iii)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 630 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iii)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 39, 40, 41](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
